Exterior of Valneva Covid-19 vaccine production facility at Livingston, Scotland, UK

RMID:2E8XXW4

Preview

Image details

Contributor:

Iain Masterton / Alamy Stock Photo

Image ID:

2E8XXW4

File size:

53.6 MB (2.1 MB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

5300 x 3535 px | 44.9 x 29.9 cm | 17.7 x 11.8 inches | 300dpi

Date taken:

28 January 2021

This image can't be licensed for personal use (e.g. personal prints).

Search stock photos by tags

britain british coronavirus pandemic covid-19 vaccine factory exterior facility industry livingston manufacturer new pharmaceutical factory pharmaceutical industry production scotland scottish uk united kingdom valneva

Similar stock images

RM2DM08TX–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2E8XXX1–Exterior of Valneva Covid-19 vaccine production facility at Livingston, Scotland, UK

RM2DM08WB–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2E8XXWH–Exterior of Valneva Covid-19 vaccine production facility at Livingston, Scotland, UK

RM2DM0902–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM08X2–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM08TB–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM08YG–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM090B–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM090R–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

Exterior of Valneva Covid-19 vaccine production facility at Livingston, Scotland, UK

Image details

Search stock photos by tags

Get great features with your free account

Get inspired for your next project!